Tutor: A multicenter, phase 1 trial of tucatinib, trastuzumab, and capecitabine with stereotactic radiosurgery for brain metastases from HER-2 positive breast cancer

Authors

Manmeet Ahluwalia
Ahmad Ozair
Mainak Bardhan
Shreyas Bellur
Dilanis Perche
Amy K. Starosciak
Atulya A. Khosla, Corewell Health Resident
Daniel S. Leon-Ariza
Muni Rubens

Document Type

Conference Proceeding

Publication Date

10-2024

Publication Title

Neuro-Oncology

Volume

26

Issue

Supplement_5

Comments

EANO 2024 Annual Meeting. European Association of Neuro-Oncology (EANO). October 17-20, 2024.Glasgow, United Kingdom.

Recommended Citation

Ahluwalia MS, Ozair A, Bardhan M, Bellur SS, Perche DC, Starosciak A et al [Khosla AA] Tutor: a multicenter, phase 1 trial of tucatinib, trastuzumab, and capecitabine with stereotactic radiosurgery for brain metastases from her-2 positive breast cancer. Neuro-Oncology. 2024 Oct;26(suppl. 5):v46.